Biotech grants in Germany
Explore Biotech grants for companies in Germany. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from German innovation agencies, research funders and foundations, EU and international programs open to applicants in Germany, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Germany come first.
Showing 481-504 of 668 grants
NIAMS P30 Centers Program
NIH · United States
Funds shared research infrastructure for skin, bone, muscle and rheumatic disease research — cores, methods expertise and workforce development.
NIH Blueprint Initiative: Tools for Germline Gene Editing in the Nervous System
NIH · United States
Funds developing and validating gene-editing tools in animal and other model systems used to study the human brain.
Novel Technologies for Rapid Proof of Clean in Professional Environments
Diversey · United States
Pays $10,000 for a genuinely new way to verify cleanliness in under 30 minutes.
Parkinson's Foundation Launch Award
Parkinson's Foundation · United States
Offers advanced support for emerging Parkinson's disease investigators developing independent, high-impact scientific programs.
Postdoctoral Fellowship
Breakthrough T1D · United States
Supports early-career postdoctoral researchers advancing type one diabetes research globally.
Q4Bio — Execution
Wellcome Leap · United States
Supports United Kingdom quantum biology research linking physics tools to biological discovery challenges.
RFA: Common Mechanisms in Autoimmunity Insight Awards
Breakthrough T1D · United States
Supports studies on common autoimmune mechanisms to inform shared treatment strategies for type 1 diabetes and related conditions.
RFA: Establishing Immune Tolerance in Islet Cell Replacement Therapy
Breakthrough T1D · United States
Funds type 1 diabetes research to improve immune tolerance pathways for safer islet-based replacement approaches.
RFA: In Vitro Disease Modeling — T1D-on-a-Chip Platforms
Breakthrough T1D · United States
Supports in vitro disease modeling for type 1 diabetes using chip-based systems and translational experimental platforms.
RFA: Translational Strategies to Define & Monitor Vascularization for Islet Therapies
Breakthrough T1D · United States
Funds translational methods to define, monitor, and improve vascularization in islet-based diabetes therapies.
Rice Business Plan Competition
Rice Jones School · United States
Funds student-led startup teams competing for investment, non-dilutive cash, and in-kind prizes at Rice University.
RTFCCR/LUNGevity Award for Overcoming Treatment Resistance
LUNGevity Foundation · United States
Provides four, clinical trial investigators addressing lung-cancer treatment resistance through the RTFCCR/LUNGevity Award for Overcoming Treatment Resistance.
Senior Research Awards
CCF · United States
Supports research teams and institutions for Senior Research Awards in biotechnology and medical technology.
Targeted Research Program on Engineered Cell Therapies for Lupus
🇺🇸LRA · United States
Runs CART and next-generation cell therapy development in lupus through the Targeted Research on Engineered Cell Therapies for.
The Missed Vital Sign — Execution
Wellcome Leap · United States
Funds United Kingdom women-centered health projects improving vital-sign linked maternal and child outcomes.
Translational Bridge Award
🇺🇸LRA · United States
Invests in lupus translational projects through the Translational Bridge Award to move discoveries toward clinical testing.
Treat FTD Fund
ADDF · Global / Multinational
Funds early-stage clinical studies for frontotemporal dementia, including prevention trials for high-risk participants.
Untangling Addiction — Execution
Wellcome Leap · United States
Supports United Kingdom addiction science projects targeting substance use mechanisms and treatment translation.
VISIBLE
Wellcome Leap · United States
Supports United Kingdom studies on coronary microvascular disease in women and translation into clinical care.
XPRIZE Healthspan — Finals Phase
XPRIZE · United States
Funds teams developing therapeutics that improve longevity through practical medical research and validation.
XPRIZE Quantum Applications — Phase II
XPRIZE · United States
Funds quantum application teams bridging fundamental discovery to practical deployment-ready technologies.
Alternative Protein R&D RFP
Coefficient · United States
Funds global R&D teams developing alternative protein ingredients and food-science methods through Coefficient Giving grant awards.
Global Health and Wellbeing in an Era of Transformative AI RFP
Coefficient · United States
Funds global teams preparing health and wellbeing systems for advanced AI through Coefficient Giving RFP grants.
Grand Challenges — Micronutrient Absorption Barriers in Fortified Foods
Gates Foundation · United States
Funds global teams researching novel approaches to overcome infection, inflammation, and microbiome-related barriers that reduce the effectiveness of food fortification programs.